Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

BioNJ Honors The Medicines Company’s Founder and CEO Dr. Clive Meanwell with 2016 Dr. Sol J. Barer Award

2/5/2016

0 Comments

 
​Parsippany, NJ -- The Medicines Company (NASDAQ:MDCO) announced that its founder and Chief Executive Officer, Clive Meanwell, MD, PhD, has been awarded the 2016 Dr. Sol J. Barer Award for Vision, Innovation, and Leadership, which was presented by BioNJ at its 23rd Annual Dinner Meeting on January 4.

Named for Sol J. Barer, PhD, founder and former Chairman and Chief Executive Officer of Celgene Corporation of Summit, New Jersey, the award recognizes outstanding research and business leaders who have made significant contributions to the growth and prosperity of the biosciences industry in New Jersey and throughout the world.
 
To view BioNJ’s Gala video honoring Dr. Meanwell, click here.
​“Dr. Sol Barer is an icon of the bioscience industry, and his dedication and commitment to innovation is nothing short of inspirational.  I humbly accept this award on behalf of all of my colleagues at The Medicines Company who achieved so much during 2015 – and we thank the BioNJ Board of Trustees for this honor,” said Clive Meanwell, MD, PhD, Chief Executive Officer, The Medicines Company.
 
BioNJ President and Chief Executive Officer Debbie Hart said, “Clive is everything a leader should be: a visionary who’s not afraid to challenge the status quo, an innovator who’s respected by patients and caregivers for his compassion and commitment to better understand their challenges, and a leader who knows how to get the job done and how to inspire a team to travel that road with him.”
 
“Since its inception in 1996, Clive has carefully guided The Medicines Company to the innovative institution it is today — known for developing products that industry experts have dubbed ‘game-changers’ in treating cardiovascular disease, infectious disease and sedation,” Hart said.
 
“At the same time,” Hart continued, “Clive has long been committed to understanding how customers value medicines, and ensuring the company delivers both medical and economic improvements that create value and build a sustainable business. Clive is so deserving of this award.”
 
At the same event, The Medicines Company was one of 16 companies who received a BioNJ Innovator Award for a new drug approval in 2015. The company had four drug approvals in the U.S. in 2015.
 
The Dr. Sol J. Barer Award for Vision, Innovation, and Leadership was established by the BioNJ Board of Trustees in March 2008 as an annual award to recognize the outstanding research and business leaders who have made and continue to make significant contributions to the growth of the biosciences in New Jersey and around the world.
 
The honoree is voted on by the BioNJ Board of Trustees from nominations taken from the Nominating Committee. The award is named for Dr. Sol J. Barer, Ph.D., who founded the biotechnology group at Celanese that was subsequently spun out to form Celgene, currently one of the world’s largest biotechnology companies.
 
The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care and serious infectious disease care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608-2002
609-858-9507